(NASDAQ: WGS) Genedx Holdings's forecast annual revenue growth rate of 18.35% is forecast to beat the US Health Information Services industry's average forecast revenue growth rate of 7.7%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.78%.
Genedx Holdings's revenue in 2026 is $454,426,000.On average, 11 Wall Street analysts forecast WGS's revenue for 2026 to be $14,408,760,684, with the lowest WGS revenue forecast at $13,797,696,819, and the highest WGS revenue forecast at $15,134,044,881. On average, 11 Wall Street analysts forecast WGS's revenue for 2027 to be $17,919,470,211, with the lowest WGS revenue forecast at $16,685,115,239, and the highest WGS revenue forecast at $19,884,179,212.
In 2028, WGS is forecast to generate $22,721,197,537 in revenue, with the lowest revenue forecast at $19,283,255,011 and the highest revenue forecast at $27,581,973,495.